4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-019772
Options or other derivatives
- Chief Product Strategy Officer acquired 81,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kieffer Tara Lynn Chief Product Strategy Officer | 2024-11-27 | Grant or award · Stock Option (right to buy) | +81,000 | 81,000 | D | ||
Loading xslF345X05/form4.xml…